Having trouble accessing articles? Reset your cache.

Vical tumbles after ischemia miss

Vical Inc. (NASDAQ:VICL) fell $1.24 (32%) to $2.62 on Wednesday after partner sanofi-aventis Group (Euronext:SAN;

Read the full 157 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE